Видео

A message from Compass's Chief Research & Development Officer, Mike Gold, this World Suicide Prevention Day. compasspathways.com/

compasspathways.com/

compasspathways.com/

compasspathways.com/

Over 100 million people around the world live with treatment-resistant depression. Watch our video to hear real patients' stories. www.compasspathways.com

Dr Steve Levine, our Senior VP of Patient Access and Medical Affairs, spoke at length with Prof Rory O’Connor on this year’s theme of ‘Zero Male Suicide’ for International Men’s Day. Prof O’Connor leads the Suicidal Behaviour Research Laboratory, a suicide and self-harm research group based in Glasgow, Scotland. If you or someone you know is struggling with thoughts of suicide, we urge you to s...

We’re proud to unveil our evolved brand and visual identity-reflecting our transition to a late-stage clinical development company. All of the faces you see in the film below are those of our team. Our purpose, told by our people

compasspathways.com/

Hear from our CEO, Kabir Nath, on COMPASS's highlights from 2022 and our plans for the year ahead. compasspathways.com/

Our Chief Medical Officer Dr Guy Goodwin talks about the publication of COMPASS's phase 2b data in the New England Journal of Medicine. compasspathways.com/

Dr Guy Goodwin, our Chief Medical Officer, talks about COMPASS's Phase 3 programme. compasspathways.com/

Our CEO, Kabir Nath, talks about COMPASS's impact strategy. compasspathways.com/

To celebrate World Quality Week, our CEO Kabir Nath shares his thoughts on what quality means to us at COMPASS. compasspathways.com/

To celebrate World Quality Week, our CEO Kabir Nath shares his thoughts on what quality means to us at COMPASS. compasspathways.com/

World Quality Week at COMPASS

COMPASS Pathways' phase 2b data published in the New England Journal of Medicine

Scott Aaronson on COMPASS Pathways' phase 2b trial

World Mental Health Day 2022: our CEO's vision for the future

Introducing Kabir Nath, COMPASS Pathways' new CEO

Dr Guy Goodwin on COMPASS's trial of COMP360 psilocybin therapy in anorexia nervosa

Dr Walter Kaye on COMPASS's trial of COMP360 psilocybin therapy in anorexia nervosa

Dr Hubertus Himmerich on COMPASS's trial of COMP360 psilocybin therapy in anorexia nervosa

COMPASS Pathways to fund study of COMP360 psilocybin in autistic adults

Living with treatment-resistant depression: Dee’s advice for others

Living with treatment-resistant depression: Dee’s story

Living with treatment-resistant depression: Eric’s story

Anne Cooke on the British Neuroscience Association’s Scholars programme

Professor Allan Young on the launch of The Centre for Mental Health Research and Innovation

David Bradley on the launch of The Centre for Mental Health Research and Innovation